Market capacity
How hard is it to move this price?
Pool liquidity
1K mana
Bid-ask spread
n/a
automated market maker
24h volume
100 mana
Total volume
736.1 mana
Play money: depth is in mana, so it says nothing about real-money conviction.
As of Oct 22, 2026, 1:34 PM ET, Manifold priced this market at 53.8% (little changed over 24 hours). It had 100 mana traded in the past 24 hours and 1K mana of pool liquidity. probcast.co rates the support behind this price as moderate.
Play-money market (mana, not dollars) — thin market where small orders can move the price, traded by a small group of accounts.
Source: Manifold price history
Is the move backed by real trading and depth?
The pricing has partial support: moderate trading volume.
Has the market settled at the new probability?
The probability has held near its current level over the past several hours.
Will the rules resolve without ambiguity?
The resolution rules are relatively specific, with a named source and a defined deadline.
Two different questions: how hard the price is to move, and whose trading set it.
How hard is it to move this price?
Pool liquidity
1K mana
Bid-ask spread
n/a
automated market maker
24h volume
100 mana
Total volume
736.1 mana
Play money: depth is in mana, so it says nothing about real-money conviction.
Whose opinion is this price?
Accounts
7
Trades
13
over 85 days
Largest order
200 mana
736.1 mana traded across these 13 trades (last 85 days).
A small group of accounts did most of the trading — neither one whale nor a broad crowd.
From the latest trade tape (most recent 200 prints) — a live activity sample, not a lifetime total.
Resolution criteria This market will resolve to YES if the total number of confirmed measles cases in the United States reported by the Centers for Disease Control and Prevention (CDC) for the calendar year 2027 is strictly greater than the total number reported for the calendar year 2026. If the 2027 count is less than or equal to the 2026 count, the market will resolve to NO.
This summary shows the opening of the venue's official rules. ProbCast has not yet generated an independent plain-English interpretation for this contract — review the full rules before relying on it.
Resolution criteria This market will resolve to YES if the total number of confirmed measles cases in the United States reported by the Centers for Disease Control and Prevention (CDC) for the calendar year 2027 is strictly greater than the total number reported for the calendar year 2026. If the 2027 count is less than or equal to the 2026 count, the market will resolve to NO. The primary source of truth will be the CDC's official Measles Cases and Outbreaks page. If this page is unavailable or no longer updated, official numbers published in the CDC's Morbidity and Mortality Weekly Report (MMWR) or the National Notifiable Diseases Surveillance System (NNDSS) will be used. Details and Edge Cases: The resolution will rely on "confirmed" U.S. cases as defined and tracked by the CDC. Because weekly provisional numbers are subject to revision, the market will resolve using the final consolidated case numbers for each year as published by the CDC (typically updated in the first half of the following year). If the cumulative provisional count for 2027 exceeds the final 2026 count at any point, the market may resolve immediately to YES. Otherwise, resolution will wait until near-final or final counts for both years are available, no later than June 30, 2028. Background Measles was declared eliminated in the United States in 2000 due to high vaccine coverage, but imported cases and subsequent transmission in under-vaccinated pockets continue to cause periodic flare-ups. The U.S. experienced a significant resurgence of measles starting in 2025 (which saw 2,289 confirmed cases). In 2026, the outbreak worsened, with the CDC reporting 2,318 confirmed cases by late July 2026—making 2026 the worst year for U.S. measles infections in 35 years. This market tracks whether this rising trend of case counts will persist into 2027, or if public health containment strategies and vaccination campaigns will succeed in bending the curve downward.
The contract must resolve based on what has happened by this date.
Derived from the contract's own mechanics as of Oct 22, 1:45 PM ET. ProbCast does not list scheduled meetings, announcements, or data releases it cannot verify.
Research signals — these models are still accumulating the history needed for full validation, and they can disagree with the headline read. Model confidence: low · expected error ±22 pts.
Thin book and/or wide spread. Small orders can move this price disproportionately, so any single print is noisy and easily overread.
Read with caution —Read the latest price with caution; conditions make it an unreliable summary right now.
Short-term motion of the price line (~1h), distinct from the environment above — not a prediction of the final outcome.
Secondary read: leaning toward Stale price.
A read-only classification of the market environment — how much weight the current price deserves as a read of consensus. It describes conditions, never a trade.